Northern Trust Corp Bio Affinity Technologies, Inc. Put Options Transaction History
Northern Trust Corp
- $572 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding BIAF
# of Institutions
15Shares Held
240KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA70.3KShares$159,6400.0% of portfolio
-
Geode Capital Management, LLC Boston, MA42.1KShares$95,5170.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny37.5KShares$85,1250.0% of portfolio
-
Captrust Financial Advisors Raleigh, NC27.9KShares$63,2980.0% of portfolio
-
State Street Corp Boston, MA17.6KShares$39,9520.0% of portfolio
About bioAffinity Technologies, Inc.
- Ticker BIAF
- Exchange
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 2,727,580
- Market Cap $6.19M
- Description
- bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is b...